Sarepta Therapeutics
SRPT
SRPT
357 hedge funds and large institutions have $1.42B invested in Sarepta Therapeutics in 2025 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 159 increasing their positions, 86 reducing their positions, and 128 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
357
Holders Change
-69
Holders Change %
-16.2%
% of All Funds
4.79%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
64
Increased
159
Reduced
86
Closed
128
Calls
$132M
Puts
$79.5M
Net Calls
+$52.1M
Net Calls Change
+$31M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$76.5M |
| 2 |
BlackRock
New York
|
+$37.8M |
| 3 |
Two Sigma Advisers
New York
|
+$29.2M |
| 4 |
Two Sigma Investments
New York
|
+$27.5M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$26.8M |
